| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,471,016 |
|
|
|
Indirect Value
|
$4,283,565 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-05-21 |
4 |
AS |
$36.88 |
$139,535 |
I/I |
(3,750) |
893,578 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2009-06-04 |
4 |
AS |
$38.82 |
$139,878 |
D/D |
(3,600) |
4,000 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-06-04 |
4 |
AS |
$37.31 |
$140,252 |
I/I |
(3,750) |
886,078 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
• – – |
2007-02-07 |
4 |
AS |
$40.52 |
$141,820 |
I/I |
(3,500) |
7,894 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-08-07 |
4 |
AS |
$47.41 |
$142,230 |
I/I |
(3,000) |
13,407 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-02-02 |
4 |
AS |
$28.55 |
$148,108 |
I/I |
(5,174) |
92,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-22 |
4 |
AS |
$39.38 |
$148,429 |
I/I |
(3,750) |
863,578 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-11-23 |
4 |
S |
$4.96 |
$148,923 |
I/I |
(30,000) |
207,925 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2009-10-01 |
4 |
AS |
$41.46 |
$150,312 |
D/D |
(3,600) |
4,000 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-07 |
4 |
AS |
$40.05 |
$152,962 |
I/I |
(3,750) |
874,828 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-08-06 |
4 |
AS |
$41.27 |
$155,013 |
I/I |
(3,750) |
859,828 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-08 |
4 |
AS |
$41.22 |
$155,142 |
I/I |
(3,750) |
871,078 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-08-07 |
4 |
AS |
$41.60 |
$155,993 |
I/I |
(3,750) |
856,078 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-21 |
4 |
AS |
$41.05 |
$156,793 |
I/I |
(3,750) |
867,328 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-05 |
4 |
AS |
$22.20 |
$157,620 |
I/I |
(7,100) |
82,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-05 |
4 |
AS |
$21.12 |
$158,078 |
I/I |
(7,357) |
77,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-06-18 |
4 |
AS |
$38.94 |
$158,565 |
I/I |
(3,750) |
882,328 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-06-19 |
4 |
AS |
$42.16 |
$160,564 |
I/I |
(3,750) |
878,578 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-08-18 |
4 |
AS |
$43.18 |
$161,925 |
I/I |
(3,750) |
852,328 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-08-19 |
4 |
AS |
$43.90 |
$168,483 |
I/I |
(3,750) |
848,578 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-04 |
4 |
AS |
$22.19 |
$168,614 |
I/I |
(7,600) |
84,225 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-09-02 |
4 |
AS |
$45.43 |
$170,415 |
I/I |
(3,750) |
841,078 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-09-01 |
4 |
AS |
$45.88 |
$172,050 |
I/I |
(3,750) |
844,828 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-11-19 |
4 |
AS |
$45.90 |
$172,560 |
I/I |
(3,750) |
771,578 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-07-10 |
4 |
AS |
$49.77 |
$174,297 |
I/I |
(3,500) |
16,407 |
|
- |
|
424 Records found
|
|
Page 11 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
